Literature DB >> 22391756

Prognostic significance of serum antioxidant parameters in immunocompetent patients with cryptococcal meningitis.

Y Liu1, Y Jiang, A Wu, S Chen, Y Zhang, M Liu, X Ma, L Ma, X Chen.   

Abstract

The purpose of this investigation was to determine whether endogenous antioxidants were prognostic factors in immunocompetent patients with cryptococcal meningitis (CM). The clinical features, alterations of serum albumin, bilirubin, and uric acid (UA) levels before and after six weeks of treatment in 94 immunocompetent patients with CM from January 2000 to December 2010 were retrospectively analyzed. The patients with CM had lower serum albumin and UA levels and higher bilirubin levels before treatment. After six weeks of treatment, the serum bilirubin levels decreased significantly and the serum UA levels increased significantly in 'cured/improved' patients. The serum UA level was negatively correlated with log cerebrospinal fluid (CSF) cryptococcal count and positively correlated with the CSF glucose level. A significantly lower level of serum UA was associated with high CSF open pressure, hydrocephalus, brain lesions, and consciousness disturbance. Moreover, the good outcome was 7.779 times more likely to occur in patients with an increase in the serum UA level ≥38.8% after six weeks of treatment. A logistic regression analysis also confirmed that an increase in the serum UA level ≥38.8% after six weeks of treatment was an independent good outcome predictor. Though there were abnormal conditions of serum antioxidants, the variation in the UA level could serve as a potential indicator of therapeutic efficacy in immunocompetent patients with CM.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22391756     DOI: 10.1007/s10096-012-1577-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  42 in total

1.  The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000.

Authors:  Sara A Mirza; Maureen Phelan; David Rimland; Edward Graviss; Richard Hamill; Mary E Brandt; Tracie Gardner; Matthew Sattah; Gabriel Ponce de Leon; Wendy Baughman; Rana A Hajjeh
Journal:  Clin Infect Dis       Date:  2003-02-27       Impact factor: 9.079

Review 2.  Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle.

Authors:  Thomas W Sedlak; Solomon H Snyder
Journal:  Pediatrics       Date:  2004-06       Impact factor: 7.124

3.  A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation.

Authors:  Ozcan Erel
Journal:  Clin Biochem       Date:  2004-04       Impact factor: 3.281

4.  Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy.

Authors:  P G Pappas; J R Perfect; G A Cloud; R A Larsen; G A Pankey; D J Lancaster; H Henderson; C A Kauffman; D W Haas; M Saccente; R J Hamill; M S Holloway; R M Warren; W E Dismukes
Journal:  Clin Infect Dis       Date:  2001-07-26       Impact factor: 9.079

Review 5.  Albumin--an important extracellular antioxidant?

Authors:  B Halliwell
Journal:  Biochem Pharmacol       Date:  1988-02-15       Impact factor: 5.858

6.  Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis.

Authors:  S Kastenbauer; U Koedel; H W Pfister
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

Review 7.  Pathogenesis of bacterial meningitis.

Authors:  S L Leib; M G Täuber
Journal:  Infect Dis Clin North Am       Date:  1999-09       Impact factor: 5.982

8.  Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

Authors:  W E Dismukes; G Cloud; H A Gallis; T M Kerkering; G Medoff; P C Craven; L G Kaplowitz; J F Fisher; C R Gregg; C A Bowles; S Shadomy; A M Stamm; R B Diasio; L Kaufman; S Soong; W C Blackwelder
Journal:  N Engl J Med       Date:  1987-08-06       Impact factor: 91.245

9.  Cryptococcal infection of the central nervous system.

Authors:  B A Everett; J A Kusske; J L Rush; H W Pribram
Journal:  Surg Neurol       Date:  1978-03

10.  Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China.

Authors:  Jianghan Chen; Ashok Varma; Mara R Diaz; Anastasia P Litvintseva; Kurt K Wollenberg; Kyung J Kwon-Chung
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

View more
  1 in total

1.  Impaired consciousness and decreased glucose concentration of CSF as prognostic factors in immunocompetent patients with cryptococcal meningitis.

Authors:  Chen Zhang; Zheren Tan; Fafa Tian
Journal:  BMC Infect Dis       Date:  2020-01-22       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.